Saveri Bhattacharya, DO, Thomas Jefferson University, talks about Vaccine Immunotherapy with Cytoxan & Interferon | Eventually add Ipilimumab or Pembrolizumab…
Browsing: Breast
Breast Cancer
Saveri Bhattacharya, DO, Thomas Jefferson University, talks about Metastatic Breast Cancer Does Well with Bria-IMT Side-Effect Profile Not as Severe…
Saveri Bhattacharya, DO, Thomas Jefferson University, talks about Phase 1 & 2 Trial of Bria-IMT | Immunotherapy with Cytoxan &…
Jennifer K. Litton, MD, explains The Number of Agents Has Exploded Impactful Studies Happen with Federal Funding at Annual Meeting…
Jennifer K. Litton, MD, MD Anderson Cancer Center, talks about TAILORx Trial is Confirmatory Group of Patients Avoiding Chemo-Therapy at…
Jennifer K. Litton, MD, MD Anderson Cancer Center, talks about Warranting Larger Ongoing Confirmatory Study Possibility of Avoiding Chemo-Therapy in…
Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Biopsies Pre- & Post-PARP inhibitors Combination Studies for Response Beyond BRCA…
Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Warrants Larger Ongoing Confirmatory Study Possibility of Avoiding Chemo-Therapy in BRCA…
Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Feasibility Study with 2 Months of Talazoparib Tumor Volume Decrease of…
Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Talazoparib – Active in Metastatic Breast Cancer Pathologic Complete Response Rate…
Chuck Wiseman, MD, BriaCell Therapeutics, talks about Rollover Protocol Approval Bria-IMT in combination with a checkpoint inhibitor at Annual Meeting…
Chuck Wiseman, MD BriaCell Therapeutics, discusses Cell Preparation Bria-IMT Confirms that similar vaccine therapies can regress advances at Annual Meeting…
Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains KLLN & SEC23B Novel Predisposition Genes Prediction tools for…
Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II…
Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains SEC23B is Very Rarely Studied in Cancer Enters the…
Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains KLLN is Right Next to PTEN Gene Might play…
Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains 3D Modeling of PTEN Tumor Suppressor at AACR 2018.